Quick Heal Technologies Ltd
Fundamental Score
Quick Heal Technologies Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of QUICKHEAL across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Strong Operating Margins (17.16%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages. This indicates sustainable profitability potential.
Robust Profit Growth (90.60%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Strong Cash Generation (₹175.68 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (71.63%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
9 factors identified
Below-Average Return on Equity (0.63%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-0.24%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Limited Growth History (-0.47% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities. Assess future growth catalysts.
Weak Earnings Growth (-46.12% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation. Consider growth catalysts and competitive positioning.
Stagnant Profit Growth (-47.96% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity. Assess transformation initiatives.
Weak Interest Coverage (-23.35x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability. Monitor cash flow and debt reduction plans.
Limited Institutional Interest (FII+DII: 2.83%)
Observation: Low institutional participation may affect liquidity and visibility.
Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Very Low ROE
Observation: Poor capital utilization and shareholder returns.
Analysis: ROE below 5% suggests significant inefficiencies in capital deployment.
Financial Statements
Comprehensive financial data for Quick Heal Technologies Ltd
About QUICKHEAL
Business Overview
Quick Heal Technologies Limited engages in the provision of security software products and solutions to consumers, small businesses, government establishments, and corporate houses in India and internationally. It offers antivirus solutions, including total security, internet security, antivirus pro, security for mac, total security for android, mobile security, total security multi-device, and internet security essentials under the Quick Heal brand, as well as consumer fraud prevention products comprising the Quick Heal AntiFraud.AI. The company also provides endpoint protection, endpoint detection and response, extended detection and response, mobile device management, BYOD, zero trust network access, and data privacy, as well as malware analysis platform and threat intel under the Seqrite brand. In addition, it offers enterprise services, including DPDP compliance and managed detection and response. Quick Heal Technologies Limited was incorporated in 1995 and is headquartered in Pune, India.
Company Details
Key Leadership
Corporate Events
QUICKHEAL Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Quick Heal Technologies Ltd (QUICKHEAL)?
As of 30 Jan 2026, 01:38 pm IST, Quick Heal Technologies Ltd (QUICKHEAL) is currently trading at ₹187.50. The stock has a market capitalization of ₹1.67K (Cr).
Is QUICKHEAL share price Overvalued or Undervalued?
QUICKHEAL is currently trading at a P/E ratio of 0.00x, compared to the industry average of 36.75x. Based on this relative valuation, the stock appears to be Fairly Valued against its sector peers.
What factors affect the Quick Heal Technologies Ltd share price?
Key factors influencing QUICKHEAL's price include its quarterly earnings growth (Sales Growth: 13.65%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Quick Heal Technologies Ltd a good stock for long-term investment?
Quick Heal Technologies Ltd shows a 5-year Profit Growth of -47.96% and an ROE of 0.63%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing.
How does Quick Heal Technologies Ltd compare with its industry peers?
Quick Heal Technologies Ltd competes with major peers in the Software Products. Investors should compare QUICKHEAL's P/E of 0.00x and ROE of 0.63% against the industry averages to determine its competitive standing.
What is the P/E ratio of QUICKHEAL and what does it mean?
QUICKHEAL has a P/E ratio of N/Ax compared to the industry average of 36.75x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹N/A for every ₹1 of annual earnings.
How is QUICKHEAL performing according to Bull Run's analysis?
QUICKHEAL has a Bull Run fundamental score of 32/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does QUICKHEAL belong to?
QUICKHEAL operates in the Software Products industry. This classification helps understand the competitive landscape and sector-specific trends affecting Quick Heal Technologies Ltd.
What is Return on Equity (ROE) and why is it important for QUICKHEAL?
QUICKHEAL has an ROE of 0.63%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Quick Heal Technologies Ltd generates profits from shareholders' equity.
How is QUICKHEAL's debt-to-equity ratio and what does it indicate?
QUICKHEAL has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is QUICKHEAL's dividend yield and is it a good dividend stock?
QUICKHEAL offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has QUICKHEAL grown over the past 5 years?
QUICKHEAL has achieved 5-year growth rates of: Sales Growth -0.47%, Profit Growth -47.96%, and EPS Growth -46.12%.
What is the promoter holding in QUICKHEAL and why does it matter?
Promoters hold 71.63% of QUICKHEAL shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is QUICKHEAL's market capitalization category?
QUICKHEAL has a market capitalization of ₹1668 crores, placing it in the Small-cap category.
How volatile is QUICKHEAL stock?
QUICKHEAL has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for QUICKHEAL?
QUICKHEAL has a 52-week high of ₹N/A and low of ₹N/A.
What is QUICKHEAL's operating profit margin trend?
QUICKHEAL has a 5-year average Operating Profit Margin (OPM) of 17.16%, indicating the company's operational efficiency.
How is QUICKHEAL's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 13.65% and YoY Profit Growth of 90.60%.
What is the institutional holding pattern in QUICKHEAL?
QUICKHEAL has FII holding of 0.50% and DII holding of 2.33%. Significant institutional holding often suggests professional confidence in the stock.